Method for the Treatment of Ischemia Reperfusion Injury
The invention is in the field of thrombosis, haemostasis, cardiology, medicinal chemistry and/or pharmacology. More particularly, it relates to the use of a mutant activated protein C (APC) for the treatment of ischemia reperfusion injury. A method is provided for treating or preventing reperfusion injury following an ischemic event that comprises administering to a subject a pharmaceutical preparation comprising a mutant APC or a precursor thereof. Compositions for use in the present invention include S360A APC or a precursor thereof and an acceptable pharmaceutical carrier.
Attached files:Patents:WO 2,009,115,548
Inventor(s):
NICOLAES GERARDUS ANNA FRANCISCUS [NL]; ROSING JAN [NL]; CATE TEN HUGO [NL]; DAHLBAECK BJOERN ULFSON [SE]
Type of Offer:
Sale
« More Pharmaceutical Patents« More Medical Patents